tocilizumab Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2/3 (1)
Unknown (1)

Interventional (1)
Observational (1)

University Hospital, Caen (1)
University of Oxford (1)

No (1)
Yes (1)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadarthritis

I am/have/hadcovid-19

I am/have/hadacute respiratory syndrome (sars)

I am/have/hadrheumatism

I am/have/hadimmunoglobulins

I am/have/hadimmunoglobulin

I am/have/hadaspirin

I am/have/hadinflammatory disorder

added new label for I am/have/had

more

I am looking for

I am looking fortocilizumab

I am looking forcorticosteroids

I am looking forsteroidal anti-inflammatory drugs

I am looking forinterleukin

I am looking forcolchicine

I am looking forimmunosuppressive agents

I am looking forhydroxychloroquine

I am looking forimmunoglobulins

I am looking forigiv

I am looking foraspirin

I am looking forimmunoglobulin

I am looking foriv immunoglobulin

I am looking forlopinavir

I am looking forazithromycin

I am looking forlopinavir/ritonavir

I am looking forritonavir

I am looking forazithormycin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For Seniors
Interventional Study
all
Family Medicine
Recruiting

Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial investigating whether treatment with either Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Convalescent plasma or Tocilizumab prevents death in patients with COVID-19.

igiv

colchicine

iv immunoglobulin

lopinavir

immunoglobulins

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Family Medicine
Recruiting

Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy

The use of anti-interleukin (IL)-6 therapy, including tocilizumab, in rheumatoid arthritis or giant cell arteritis, led to the improvement or even control of disease in some patients for whom no further therapeutic options were available.

steroidal anti-inflammatory drugs

inflammatory disorder

interleukin

immunosuppressive agents

tocilizumab

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.